These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2862125)

  • 1. Use of aspartame in pregnancy.
    Sturtevant FM
    Int J Fertil; 1985; 30(1):85-7. PubMed ID: 2862125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saccharin and aspartame. Are they safe to consume during pregnancy?
    London RS
    J Reprod Med; 1988 Jan; 33(1):17-21. PubMed ID: 3351801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct and indirect cellular effects of aspartame on the brain.
    Humphries P; Pretorius E; Naudé H
    Eur J Clin Nutr; 2008 Apr; 62(4):451-62. PubMed ID: 17684524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative metabolism of aspartame in experimental animals and humans.
    Ranney RE; Oppermann JA; Muldoon E; McMahon FG
    J Toxicol Environ Health; 1976 Nov; 2(2):441-51. PubMed ID: 827618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the metabolism of the aspartyl moiety of aspartame in experimental animals and man.
    Ranney RE; Oppermann JA
    J Environ Pathol Toxicol; 1979; 2(4):979-85. PubMed ID: 376770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can aspartame meet our expectations?
    Horwitz DL; Bauer-Nehrling JK
    J Am Diet Assoc; 1983 Aug; 83(2):142-6. PubMed ID: 6348131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspartame metabolism in normal adults, phenylketonuric heterozygotes, and diabetic subjects.
    Filer LJ; Stegink LD
    Diabetes Care; 1989 Jan; 12(1):67-74. PubMed ID: 2653751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of loading doses of aspartame by two phenylketonuric (PKU) children compared with two normal children.
    Koch R; Schaeffler G; Shaw NF
    J Toxicol Environ Health; 1976 Nov; 2(2):459-69. PubMed ID: 1011297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and clinical effects of aspartame in patients with chronic, stable alcoholic liver disease.
    Hertelendy ZI; Mendenhall CL; Rouster SD; Marshall L; Weesner R
    Am J Gastroenterol; 1993 May; 88(5):737-43. PubMed ID: 8480740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspartame administration to the infant monkey: hypothalamic morphology and plasma amino acid levels.
    Reynolds WA; Stegink LD; Filer LJ; Renn E
    Anat Rec; 1980 Sep; 198(1):73-85. PubMed ID: 7457932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological properties of aspartame. I. Evaluation of central nervous system effects.
    Potts WJ; Bloss JL; Nutting EF
    J Environ Pathol Toxicol; 1980; 3(5-6):341-53. PubMed ID: 7441089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biological properties of aspartame. V. Effects on a variety of physiological parameters related to inflammation and metabolism.
    Aspinall RL; Saunders RN; Pautsch WF; Nutting EF
    J Environ Pathol Toxicol; 1980; 3(5-6):387-95. PubMed ID: 6108346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood methanol concentrations in normal adult subjects administered abuse doses of aspartame.
    Stegink LD; Brummel MC; McMartin K; Martin-Amat G; Filer LJ; Baker GL; Tephly TR
    J Toxicol Environ Health; 1981 Feb; 7(2):281-90. PubMed ID: 7230276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of aspartame and phenylalanine on meal-time food intake of humans.
    Anderson GH; Leiter LA
    Appetite; 1988; 11 Suppl 1():48-53. PubMed ID: 3056266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and erythrocyte concentrations of free amino acids in adult humans administered abuse doses of aspartame.
    Stegink LD; Filer LJ; Baker GL
    J Toxicol Environ Health; 1981 Feb; 7(2):291-305. PubMed ID: 7230277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aspartame and aspartate loading upon plasma and erythrocyte free amino acid levels in normal adult volunteers.
    Stegink LD; Filer LJ; Baker GL
    J Nutr; 1977 Oct; 107(10):1837-45. PubMed ID: 903828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspartame intolerance.
    Garriga MM; Metcalfe DD
    Ann Allergy; 1988 Dec; 61(6 Pt 2):63-9. PubMed ID: 3061324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of aspartame by apparently healthy children and adolescents.
    Frey GH
    J Toxicol Environ Health; 1976 Nov; 2(2):401-15. PubMed ID: 137987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies.
    Magnuson BA; Burdock GA; Doull J; Kroes RM; Marsh GM; Pariza MW; Spencer PS; Waddell WJ; Walker R; Williams GM
    Crit Rev Toxicol; 2007; 37(8):629-727. PubMed ID: 17828671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma, erythrocyte and human milk levels of free amino acids in lactating women administered aspartame or lactose.
    Stegink LD; Filer LJ; Baker GL
    J Nutr; 1979 Dec; 109(12):2173-81. PubMed ID: 512705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.